Company news
Shanghai Medicilon, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Announcement on Equity Change of Shareholders Reaching 1% and Results of Shareholding Reduction
May 30, 2025
Medicilon Passes FDA Inspection, Reinforcing Global R&D Excellence
May 29, 2025
Announcement on Repurchasing 1% Shares through Call Auction and Progress in Repurchasing Shares
May 28, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 13, 2025
Announcement on Share Reduction Plan for Shareholder
April 29, 2025
Announcement on Attending the Annual Collective Performance Briefing for Innovative Drug Industry on SSE STAR Market 2024 and Convening Q1 2025 Performance Briefing
April 25, 2025
Announcement on Initially Repurchasing the Company's Shares through Call Auction
April 22, 2025
Announcement on Provision for Asset Impairment and Write-off of Assets in 2024
April 21, 2025
Announcement on the Progress of Half Repurchase Period
April 11, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Announcement on Postponing Some Investment Projects Financed by Raised Funds
January 24, 2025
Annual Earnings Preannouncement for 2024
January 17, 2025
Announcement on Electing Chairman, Chairman of the Board of Supervisors, and Members of Special Committees of the Board of Directors, and Appointing Senior Management Members and Securities Affairs Representative
January 13, 2025
Announcement on Shareholdings of Top 10 Shareholders and Top 10 Holders of Shares Without Sales Restrictions Concerning Share Repurchase
January 9, 2025